Angiotensin II protects cortical neurons against oxygen‑glucose deprivation‑induced injury in vitro

Tang,Mingtan; Zhao,Li; Chen,Yanqing; Wang,Lixiang; Zhang,Xiumei

doi:10.3892/br.2013.182

Angiotensin II protects cortical neurons against oxygen‑glucose deprivation‑induced injury in vitro

Authors:
- Mingtan Tang
- Li Zhao
- Yanqing Chen
- Lixiang Wang
- Xiumei Zhang
View Affiliations

Affiliations: Department of Pharmacology, Shandong University School of Medicine, Jinan, Shandong 250012, P.R. China
Published online on: October 7, 2013 https://doi.org/10.3892/br.2013.182
Pages: 112-116

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ischemic cerebrovascular disease is a common type of cerebrovascular disease and the leading cause of disability and mortality worldwide. Therefore, it is crucial to elucidate its pathogenesis and develop novel therapeutic strategies. This study was performed to investigate whether angiotensin (ang) II exerts a protective effect against cerebral ischemia̸reperfusion (I/R) injury in vitro. The primary cultured neurons were prepared and an I/R model was established by incubation of cortical neurons with Na2S2O4, followed by culture in fresh medium. The protective effect of ang II and its underlying mechanisms were investigated by morphology observation, MTT assay, flow cytometry analysis and reverse transcription‑polymerase chain reaction (RT‑PCR). The data demonstrated that ang II significantly ameliorated the neuronal injury caused by oxygen‑glucose deprivation. Furthermore, ang II increased cell viability through inhibiting cell apoptosis. The RT‑PCR results revealed that ang II was able to reverse the increased bax mRNA and the decreased bcl2 mRNA expression. Of note, the protective activity of ang II may be attenuated by co‑treatment with ang II type 2 (AT2) receptor blockade (PD123319), but not ang II type 1 (AT1) receptor blockade (valsartan). These findings suggested that ang II exerted a protective effect against neuronal injury induced by oxygen‑glucose deprivation through decreasing cell apoptosis. Therefore, ang II may be used as a potential therapeutic target in the future.

View Figures

View References

1	Read SJ, Hirano T, Davis SM and Donnan GA: Limiting neurological damage after stroke: a review of pharmacological treatment options. Drugs Aging. 14:11–39. 1999. View Article : Google Scholar : PubMed/NCBI
2	Baron JC: Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis. 11(Suppl 1): 2–8. 2001. View Article : Google Scholar : PubMed/NCBI
3	Okouchi M, Ekshyyan O, Maracine M and Aw TY: Neuronal apoptosis in neurodegeneration. Antioxid Redox Signal. 9:1059–1096. 2007. View Article : Google Scholar
4	Broughton BR, Reutens DC and Sobey CG: Apoptotic mechanisms after cerebral ischemia. Stroke. 40:e331–e339. 2009. View Article : Google Scholar : PubMed/NCBI
5	Niizuma K, Yoshioka H, Chen H, et al: Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta. 1802:92–99. 2010. View Article : Google Scholar : PubMed/NCBI
6	Shamas-Din A, Kale J, Leber B and Andrews DW: Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb Perspect Biol. 5:a0087142013. View Article : Google Scholar : PubMed/NCBI
7	Youle RJ and Strasser A: The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 9:47–59. 2008. View Article : Google Scholar : PubMed/NCBI
8	Ayaloglu-Butun F, Terzioglu-Kara E, Tokcaer-Keskin Z and Akcali KC: The effect of estrogen on bone marrow-derived rat mesenchymal stem cell maintenance: inhibiting apoptosis through the expression of Bcl-xL and Bcl-2. Stem Cell Rev. 8:393–401. 2012. View Article : Google Scholar : PubMed/NCBI
9	Warren JS, Zhao Y, Yung R and Desai A: Recombinant human erythropoietin suppresses endothelial cell apoptosis and reduces the ratio of Bax to Bcl-2 proteins in the aortas of apolipoprotein E-deficient mice. J Cardiovasc Pharmacol. 57:424–433. 2011. View Article : Google Scholar : PubMed/NCBI
10	Ramin M, Azizi P, Motamedi F, Haghparast A and Khodagholi F: Inhibition of JNK phosphorylation reverses memory deficit induced by β-amyloid (1–42) associated with decrease of apoptotic factors. Behav Brain Res. 217:424–431. 2011.PubMed/NCBI
11	Wysocki J, Ye M, Rodriguez E, et al: Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension. 55:90–98. 2010. View Article : Google Scholar : PubMed/NCBI
12	Reis WL, Saad WA, Camargo LA, Elias LL and Antunes-Rodrigues J: Central nitrergic system regulation of neuroendocrine secretion, fluid intake and blood pressure induced by angiotensin-II. Behav Brain Funct. 6:642010. View Article : Google Scholar : PubMed/NCBI
13	Grobe JL, Grobe CL, Beltz TG, et al: The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab. 12:431–442. 2010. View Article : Google Scholar : PubMed/NCBI
14	Cao X, Peterson JR, Wang G, et al: Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain. Hypertension. 59:869–876. 2012. View Article : Google Scholar : PubMed/NCBI
15	McCarthy CA, Vinh A, Broughton BR, Sobey CG, Callaway JK and Widdop RE: Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats. Hypertension. 60:1531–1537. 2012. View Article : Google Scholar : PubMed/NCBI
16	Pont-Lezica L, Colasse S and Bessis A: Depletion of microglia from primary cellular cultures. Methods Mol Biol. 1041:55–61. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wang H, Yu P, Gou H, et al: Cardioprotective effects of 20(S)-ginsenoside Rh2 against doxorubicin-induced cardiotoxicity in vitro and in vivo. Evid Based Complement Alternat Med. 2012:5062142012.PubMed/NCBI
18	Wang H, Yu P, Bai J, et al: Ocotillol enhanced the antitumor activity of doxorubicin via p53-dependent apoptosis. Evid Based Complement Alternat Med. 2013:4685372013.PubMed/NCBI
19	Xilouri M and Stefanis L: Autophagy in the central nervous system: implications for neurodegenerative disorders. CNS Neurol Disord Drug Targets. 9:701–719. 2010. View Article : Google Scholar : PubMed/NCBI
20	Zhou T, Jiang J, Zhang M, Fu Y, Yang Z and Jiang L: Protective effect of mild hypothermia on oxygen-glucose deprivation injury in rat hippocampal neurons after hypoxia. Mol Med Rep. 7:1859–1864. 2013.PubMed/NCBI
21	Dominguez C, Delgado P, Vilches A, et al: Oxidative stress after thrombolysis-induced reperfusion in human stroke. Stroke. 41:653–660. 2010. View Article : Google Scholar : PubMed/NCBI
22	Zhang X, Chen Y, Jenkins LW, Kochanek PM and Clark RS: Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury. Crit Care. 9:66–75. 2005. View Article : Google Scholar : PubMed/NCBI
23	Krysko DV, Vanden Berghe T, D’Herde K and Vandenabeele P: Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods. 44:205–221. 2008. View Article : Google Scholar : PubMed/NCBI
24	Kaschina E and Unger T: Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 12:70–88. 2003. View Article : Google Scholar : PubMed/NCBI
25	Goldenberg I, Grossman E, Jacobson KA, Shneyvays V and Shainberg A: Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. J Hypertens. 19:1681–1689. 2001. View Article : Google Scholar : PubMed/NCBI
26	Fortuno MA, Ravassa S, Etayo JC and Diez J: Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: effects of AT1 blockade with losartan. Hypertension. 32:280–286. 1998. View Article : Google Scholar : PubMed/NCBI